Open AccessOmalizumab for management of refractory urticaria: Experience of a tertiary care centre in Eastern India
Author(s) -
Shekhar Neema,
Manas Chatterjee
Publication year - 2018
Publication title -
indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_342_16
Subject(s) - medicine , tertiary care , omalizumab , refractory (planetary science) , dermatology , family medicine , immunology , immunoglobulin e , antibody , physics , astrobiology
To study the effects of omalizumab in chronic spontaneous urticaria in Indian patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom